52 FGD1 Splice Variant in Clear Cell Renal Cell Carcinoma is a Novel Biomarker for Inferior Clinical Outcomes and Development of Brain and Bone Metastases - Kendrick Yim; Alyssa Obermayer; Kapil Avasthi; Youngchul Kim; Alex Soupir; Mitchell Hayes; Andrew Chang; Joshua Davis; Roy Elias; Nirmish Singla; Michelle Churchman; Daniel Grass; et al. (The Oncologist, 2026)